We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report: Biosimilars Slashing Prices, Improving Access Across EEA
Report: Biosimilars Slashing Prices, Improving Access Across EEA
The introduction of biosimilars to certain European countries has lowered drug prices by 50 percent to 60 percent in certain therapy areas, a report says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor